Completed NA INTERVENTIONAL 2-arm NCT02492347

Effect of Antenatal SSRI Exposure on the QT Interval of Neonates (SSRIs)

Is Antenatal Exposure to Selective Serotonin Reuptake Inhibitors (SSRIs) Associated With Prolongation of the QT Interval in Term Neonates (Greater Than 37 Complete Weeks Gestation)?

Sponsor: University of Southampton

Conditions Adverse Effect of Selective Serotonin Reuptake Inhibitors Qt Interval, Variation in

Interventions Electrocardiogram

Updated 6 times since 2017 Last updated: Nov 2, 2017 Started: Feb 18, 2016 Primary completion: Aug 18, 2017 Completion: Aug 18, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Adverse Effect of Selective Serotonin Reuptake Inhibitors and Qt Interval, Variation in, this trial is completed. The trial is conducted by University of Southampton and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Dec 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Dec 2017 [monthly]

Recruiting NA

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Southampton

Data source: University of Southampton

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Southampton, United Kingdom